Ramucirumab
Products Ramucirumab is commercially available as a concentrate for the preparation of an infusion solution (Cyramza). It was approved in many countries in 2015. Structure and properties Ramucirumab is a human IgG1 monoclonal antibody with a molecular mass of 147 kDa that binds to the extracellular domain of VEGFR-2. Ramucirumab is produced by biotechnological methods. … Ramucirumab